Surgery

VTE occurs in 13 percent of head, neck cancer surgery cases

(HealthDay)—Venous thromboembolism (VTE) rates in a prospective cohort of head and neck cancer surgical patients are higher than previously reported in retrospective studies, according to research published online Sept. ...

Oncology & Cancer

Merck KGaA suffers setback for cancer drug

German pharmaceuticals maker Merck KGaA said Tuesday it is withdrawing its application for its drug Erbitux to be used to treat patients with lung cancer.

Oncology & Cancer

2012 to 2014 saw 41,185 U.S. patients with skin malignancy

From 2012 to 2014, 41,185 patients with a diagnosis of skin malignancy of the head and neck region were identified, mostly with a diagnosis of nonmelanoma skin cancer (NMSC), according to a study recently published in the ...

Medical research

The YAP signal plays a crucial role in head-and-neck cancer onset

Joint research between Kobe University and National Hospital Organization Kyushu Cancer Center has revealed that mice with mutations in the YAP signal pathway develop head and neck cancer over an extremely short period of ...

Medical research

Technique spots disease using immune cell DNA

When a person is sick, there is a tell-tale sign in their blood: a different mix of the various types of immune cells called leukocytes. A group of scientists at several institutions including Brown University has discovered ...

page 15 from 19